Cargando…
Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to est...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478950/ https://www.ncbi.nlm.nih.gov/pubmed/37675190 http://dx.doi.org/10.2147/PRBM.S425537 |
_version_ | 1785101460755709952 |
---|---|
author | Techapoonpon, Kamolvisa Kerdchareon, Nitchawan Polruamngern, Nongnuch Chalermrungroj, Teeraphan Srikhamdokkhae, Orranee Matangkarat, Premyuda |
author_facet | Techapoonpon, Kamolvisa Kerdchareon, Nitchawan Polruamngern, Nongnuch Chalermrungroj, Teeraphan Srikhamdokkhae, Orranee Matangkarat, Premyuda |
author_sort | Techapoonpon, Kamolvisa |
collection | PubMed |
description | PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to estimate the prevalence, severity and associated factors of stigma experienced by patients who recovered from COVID-19 and reintegrated into their communities. The insights gained from this study are not only beneficial to COVID-19 but can also be used as a background information in future epidemics. PATIENTS AND METHODS: This study consisted of two phases. The first phase involved the translation and validation of the COVID-19-related stigma questionnaire. The second phase was a questionnaire-based cross-sectional survey conducted between January and February 2022, at the Vajira Hospital, Bangkok, Thailand. A series of questionnaires regarding stigma, negative emotions (Depression Anxiety Stress Scale-21), and personal information were administered to COVID-19 patients who were already discharged and returned to their communities from June 2021 to February 28, 2022 (N = 354). RESULTS: The prevalence of stigma among the patients who recovered from COVID-19 was 57.9%. These were classified as mild (28.2%), moderate (21.5%), and severe (8.2%). Pearson’s correlation analysis revealed that longer admissions (r = - 0.151, p = 0.001) and longer duration from discharge (r = - 0.222, p = 0.001) were related to lower stigma. Higher stigma was associated with higher levels of depression (r = 0.528, p <0.001), anxiety (r = 0.506, p <0.001) and stress (r = 0.583, p <0.001). CONCLUSION: Social stigma related to COVID-19 in Thailand declined during the post-vaccination period. However, this issue did not disappear, and still took a toll on mental health. Our findings suggested that providing appropriate assessment and help to the patients who recovered from COVID-19 is essential, even in the post-vaccination period. |
format | Online Article Text |
id | pubmed-10478950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-104789502023-09-06 Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors Techapoonpon, Kamolvisa Kerdchareon, Nitchawan Polruamngern, Nongnuch Chalermrungroj, Teeraphan Srikhamdokkhae, Orranee Matangkarat, Premyuda Psychol Res Behav Manag Original Research PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to estimate the prevalence, severity and associated factors of stigma experienced by patients who recovered from COVID-19 and reintegrated into their communities. The insights gained from this study are not only beneficial to COVID-19 but can also be used as a background information in future epidemics. PATIENTS AND METHODS: This study consisted of two phases. The first phase involved the translation and validation of the COVID-19-related stigma questionnaire. The second phase was a questionnaire-based cross-sectional survey conducted between January and February 2022, at the Vajira Hospital, Bangkok, Thailand. A series of questionnaires regarding stigma, negative emotions (Depression Anxiety Stress Scale-21), and personal information were administered to COVID-19 patients who were already discharged and returned to their communities from June 2021 to February 28, 2022 (N = 354). RESULTS: The prevalence of stigma among the patients who recovered from COVID-19 was 57.9%. These were classified as mild (28.2%), moderate (21.5%), and severe (8.2%). Pearson’s correlation analysis revealed that longer admissions (r = - 0.151, p = 0.001) and longer duration from discharge (r = - 0.222, p = 0.001) were related to lower stigma. Higher stigma was associated with higher levels of depression (r = 0.528, p <0.001), anxiety (r = 0.506, p <0.001) and stress (r = 0.583, p <0.001). CONCLUSION: Social stigma related to COVID-19 in Thailand declined during the post-vaccination period. However, this issue did not disappear, and still took a toll on mental health. Our findings suggested that providing appropriate assessment and help to the patients who recovered from COVID-19 is essential, even in the post-vaccination period. Dove 2023-09-01 /pmc/articles/PMC10478950/ /pubmed/37675190 http://dx.doi.org/10.2147/PRBM.S425537 Text en © 2023 Techapoonpon et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Techapoonpon, Kamolvisa Kerdchareon, Nitchawan Polruamngern, Nongnuch Chalermrungroj, Teeraphan Srikhamdokkhae, Orranee Matangkarat, Premyuda Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title | Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title_full | Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title_fullStr | Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title_full_unstemmed | Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title_short | Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors |
title_sort | stigma experienced by patients who recovered from covid-19 in post-vaccination period in thailand; prevalence and associated factors |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478950/ https://www.ncbi.nlm.nih.gov/pubmed/37675190 http://dx.doi.org/10.2147/PRBM.S425537 |
work_keys_str_mv | AT techapoonponkamolvisa stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors AT kerdchareonnitchawan stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors AT polruamngernnongnuch stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors AT chalermrungrojteeraphan stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors AT srikhamdokkhaeorranee stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors AT matangkaratpremyuda stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors |